Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-13

Clinical Trial Update: Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Diet Supplementation in Pediatric Cystic Fibrosis [NA]

View source ↗

Summary

Pediatric cystic fibrosis trial investigating whether Lactobacillus probiotic supplementation modulates intestinal and pulmonary inflammation; the study is term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus probiotic dietary supplement (Lactobacillus spp.)

Snippet

Sponsor: Cantonal Hospital of St. Gallen | Conditions: Pulmonary Inflammation, Cystic Fibrosis | NA | Status: TERMINATED